We fund vital research into tests, treatments and the causes of
prostate cancer. For years, prostate cancer has been badly
underfunded. This year we have invested over £11.5 million
into research, our biggest spend so far - but we need to go much
further to find the answers that will help more men survive.
Read all about our key achievements in the past year in our Research Review 2013/14.